A carregar...
Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
Lung cancer is the most common cancer and the leading cause of cancer death worldwide, with an estimated 2.1 million new cases and 1.8 million deaths in 2018. Although small cell lung cancer (SCLC) is the most aggressive type of lung cancer, it shows high response rates to chemotherapy in early line...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580132/ https://ncbi.nlm.nih.gov/pubmed/31354294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S204577 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|